New technology for prevention and control of infectious bovine respiratory diseases.
Recent advances in molecular biology, genetics, and immunochemistry have provided the basis for a new generation of vaccines, diagnostic tools, and prophylactic substances for the prevention of infectious diseases in cattle. This article describes how these new technologies are being applied to veterinary medicine and their potential in bovine respiratory diseases caused by infectious agents.
T
T
Yilma
R
R
Breeze
D000276:Adjuvants, Immunologic; D000818:Animals; D000911:Antibodies, Monoclonal; D002417:Cattle; D002418:Cattle Diseases / Q000175:diagnosis / Q000517:prevention & control*; D007109:Immunity / Q000187:drug effects; D007372:Interferons / Q000494:pharmacology; D007376:Interleukin-2 / Q000276:immunology; D007978:Levamisole / Q000494:pharmacology; D009696:Nucleic Acids / Q000032:analysis; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000517:prevention & control / Q000662:veterinary*; D013773:Tetramisole / Q000494:pharmacology; D014611:Vaccination / Q000662:veterinary; D014613:Vaccines, Attenuated; D014616:Vaccinia virus; D014765:Viral Vaccines
D000276:Adjuvants, Immunologic; D000911:Antibodies, Monoclonal; D007376:Interleukin-2; D009696:Nucleic Acids; D014613:Vaccines, Attenuated; D014765:Viral Vaccines; D007978:Levamisole; D007372:Interferons; D013773:Tetramisole